The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates^*

References

• National Osteoporosis Foundation. Fast facts. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm [Last accessed 7 November 2006]
   Google Scholar
• Magaziner J, Simonsick EM, Kashner TM, et al. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990;45:M101–7
   PubMedGoogle Scholar
• Fink HA, Ensrud KE, Nelson DB, et al. Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). Osteoporos Int 2003;14:69–76
   PubMed Web of Science ®Google Scholar
• Huang C, Ross PD, Wasnich RD. Vertebral fractures and other predictors of back pain among older women. J Bone Miner Res 1996;11:1026–32
   Google Scholar
• Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998;128:793–800
   PubMed Web of Science ®Google Scholar
• Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348:1535–41
   PubMed Web of Science ®Google Scholar
• Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003;9:544–64
   PubMedGoogle Scholar
• ACOG Committee on Practice. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Osteo porosis. Number 50. Obstet Gynecol 2004;103:203–16
   PubMedGoogle Scholar
• Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167:S1–34
   Google Scholar
• National Osteoporosis Foundation. Physician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation, 2003
   Google Scholar
• Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007;18:1023–31
   PubMed Web of Science ®Google Scholar
• Papaioannou A, Kennedy CC, Dolovich L, et al. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 2007;24:37–55
   PubMed Web of Science ®Google Scholar
• Seeman E, Compston J, Adachi J, et al. Non-compliance: the Achilles’ heel of anti-fracture efficacy. Osteoporos Int 2007;18:711–19
   PubMed Web of Science ®Google Scholar
• Yood RA, Emani S, Reed JI, et al. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int 2003;14:965–8
   PubMed Web of Science ®Google Scholar
• Caro J, Ishak K, Huybrechts K, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004;15:1003–8
   PubMed Web of Science ®Google Scholar
• McCombs J, Thiebaud P, McLaughlin-Miley C, Shi J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004;48:271–87
   Google Scholar
• Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2006;38:922–8
   Google Scholar
• Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006;81:1013–22
   PubMed Web of Science ®Google Scholar
• van den Boogaard CH, Breekveldt-Postma NS, Borggreve SE, et al. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Curr Med Res Opin 2006;22:1757–64
   PubMed Web of Science ®Google Scholar
• Gold DT, Martin BC, Frytak JR, et al. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin 2007;23:585–94
   PubMed Web of Science ®Google Scholar
• Penning-van Beest FJ, Erkens JA, Olson M, Herings RM. Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int 2007. Published article online: 14 Sep 14 2007 doi:10.1007/s00198–007–0466–1
   Google Scholar
• Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 2007;18:271–7
   PubMed Web of Science ®Google Scholar
• Hamilton B, McCoy K, Taggart H. Tolerability and compliance with risedronate in clinical practice. Osteoporos Int 2003;14:259–62
   Google Scholar
• Turbi C, Herrero-Beaumont G, Acebes JC, et al. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 2004;26:245–56
   PubMed Web of Science ®Google Scholar
• Segal E, Tamir A, Ish-Shalom S. Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J 2003;5:859–62
   Google Scholar
• Tosteson AN, Grove MR, Hammond CS, et al. Early discontin uation of treatment for osteoporosis. Am J Med 2003;115:209–16
   PubMed Web of Science ®Google Scholar
• Burgener M, Arnold M, Katz JN, et al. Older adults’ knowledge and beliefs about osteoporosis: results of semistructured interviews used for the development of educational materials. J Rheumatol 2005;32:673–7
   PubMed Web of Science ®Google Scholar
• International Osteoporosis Foundation. The adherence gap: why osteoporosis patients don’t continue with treatment. Available at: http://www.osteofound.org/publications/adherence_gap_report.html [Last accessed 14 July 2006]
   Google Scholar
• Zafran N, Liss Z, Peled R, et al. Incidence and causes for failure of treatment of women with proven osteoporosis. Osteoporos Int 2005;16:1375–83
   PubMed Web of Science ®Google Scholar
• Carr AJ, Thompson PW, Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteo porosis: a cross-sectional survey. Osteoporos Int 2006;17:1638–44
   Google Scholar
• Pickney CS, Arnason JA. Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 2005;16:1156–60
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Ohno S, Hattori H, Ishigatsubo Y. Persistence with bisphosphonate therapy including treatment courses with multiple sequential bisphosphonates in the real world. Osteoporos Int 2007;18:1421–7
   PubMed Web of Science ®Google Scholar
• Jakob F, Marin F, Martin-Mola E, et al. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). QJM 2006;99:531–43
   Google Scholar
• Penning-van Beest FJ, Goettsch WG, Erkens JA, Herings RM. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Clin Ther 2006;28:236–42
   Google Scholar
• Rossini M, Bianchi G, Di Munno O, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteo poros Int 2006;17:914–21
   PubMed Web of Science ®Google Scholar
• Kamatari M, Koto S, Ozawa N, et al. Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Miner Metab 2007;25:302–9
   PubMed Web of Science ®Google Scholar
• Ringe JD, Christodoulakos GE. Patient compliance with alen dronate, risedronate and raloxifene for the treatment of osteo porosis in postmenopausal women. Curr Med Res Opin 2007. Published article online: 19 Sep 2007 doi:10.1185/03007x226357
   Google Scholar
• Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985;20:29–37
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555–67
   PubMed Web of Science ®Google Scholar
• Unson C, Siccion E, Gaztambide J, et al. Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Womens Health 2003;12:1037–45
   PubMed Web of Science ®Google Scholar
• Horne R, Sumner S, Jubraj B, et al. Haemodialysis patients’ beliefs about treatment: implications for adherence to medication and fluid-diet restrictions. Int J Pharm Pract 2001;9:169–75
   Google Scholar
• Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17:17–32
   Web of Science ®Google Scholar
• Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002;54:1481–96
   PubMed Web of Science ®Google Scholar
• Butler JA, Peveler RC, Roderick P, et al. Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 2004;19:3144–9
   PubMed Web of Science ®Google Scholar
• Horne R, Buick D, Fisher M, et al. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004;15:38–44
   PubMed Web of Science ®Google Scholar
• Ross S, Walker A, MacLeod MJ. Patient compliance in hyper-tension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004;18:607–13
   PubMed Web of Science ®Google Scholar
• Brown C, Battista DR, Bruehlman R, et al. Beliefs about anti-depressant medications in primary care patients: relationship to self-reported adherence. Med Care 2005;43:1203–7
   PubMed Web of Science ®Google Scholar
• Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005;44:762–7
   PubMed Web of Science ®Google Scholar
• De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother 2006;40:414–20
   Google Scholar
• Phatak HM, Thomas J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 2006;40:1737–42
   PubMed Web of Science ®Google Scholar
• Horne R, Cooper V, Gellaitry G, et al. Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr 2007;45:334–41
   PubMed Web of Science ®Google Scholar
• Cline RR, Farley JF, Hansen RA, Schommer JC. Osteoporosis beliefs and antiresorptive medication use. Maturitas 2005;50:196–208
   PubMed Web of Science ®Google Scholar
• Unson CG, Fortinsky R, Prestwood K, Reisine S. Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors. J Community Health 2005;30:281–97
   PubMed Web of Science ®Google Scholar
• Cline RR, Worley MM. Osteoporosis health beliefs and self-care behaviors: an exploratory investigation. J Am Pharm Assoc 2006;46:356–63
   Google Scholar
• Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95:1085–90
   Google Scholar
• World Health Organization. Adherence to Long-Term Therapies. Geneva Switzerland: World Health Organization, 2003
   Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–97
   PubMed Web of Science ®Google Scholar
• Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol 2001;54:S57–60
   PubMed Web of Science ®Google Scholar
• Ockene IS, Hayman LL, Pasternak RC, et al. Task force #4 – adherence issues and behavior changes: achieving a long-term solution. J Am Coll Cardiol 2002;40:630–40
   PubMed Web of Science ®Google Scholar
• Morrison A, Wertheimer AI. Compilation of quantitative overviews of studies of adherence. Drug Inf J 2004;38:197–210
   Web of Science ®Google Scholar
• Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005;22:313–56
   PubMed Web of Science ®Google Scholar
• Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1978
   Google Scholar
• McHorney C. Methodological and psychometric issues in health status assessment across populations and applications. In: Albrecht GL, Fitzpatrick R, eds. Advances in Medical Sociology, Vol. 5. Stamford CT: JAI Press, Inc., 1994:281–304
   Google Scholar
• McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 1994;32:40–66
   Google Scholar
• McHorney C. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 1997;127:743–50
   PubMed Web of Science ®Google Scholar
• McHorney C. Health status assessment methods for adults: past accomplishments and future challenges. Annu Rev Public Health 1999;20:309–35
   PubMed Web of Science ®Google Scholar
• McHorney C. Ten recommendations for advancing patient-centered outcomes measurement for older persons. Ann Intern Med 2003;139:403–9
   PubMed Web of Science ®Google Scholar
• International Osteoporosis Foundation. How fragile is her future? Available at: http://www.iofbonehealth.org/policy-advocacy/iof-policy-publications/how-fragile-is-her-future-2000–2002.html [Last accessed 18 July 2006]
   Google Scholar
• Resnick B, Wehren L, Orwig D. Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales. Orthop Nurs 2003;22: 139–47
   Google Scholar
• National Osteoporosis Foundation. Health issues survey: attitudes and actions regarding osteoporosis. Available at: http://www.nof.org/news/pressreleases/Health_Issues_Survey_Osteoporosis.pdf [Last accessed 18 Jul 2006]
   Google Scholar
• Jachna C, Forbes-Thompson S. Osteoporosis: health beliefs and barriers to treatment in an assisted living facility. J Gerontol Nurs 2005;31:25–30
   Google Scholar
• Weiss T, Gold D, Silverman S, McHorney CA. An evaluation of patient preferences for osteoporosis medications and their attributes: results from the PREFER-US Study. Curr Med Res Opin 2006;22:949–60
   PubMed Web of Science ®Google Scholar
• Miller L, Huffman H, Weidmer B, Hays R. Patient preferences regarding antiretroviral therapy. Int J STD AIDS 2002;13:593–601
   PubMed Web of Science ®Google Scholar
• Keen R, Jodar E, Iolascon G, et al. European women’s preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency. Curr Med Res Opin 2006;22:2375–81
   PubMed Web of Science ®Google Scholar
• DiMatteo M, Haskard K, Williams S. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care 2007;45:521–8
   Google Scholar
• Elliott RA, Ross-Degnan D, Adams AS, et al. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med 2007;22:805–80
   PubMed Web of Science ®Google Scholar
• Piette JD, Heisler M, Horne R, Alexander GC. A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures. Soc Sci Med 2006;62:846–57
   PubMed Web of Science ®Google Scholar
• Zhang Q, Sautner Z, Shuvayu S. Real life persistency with Fosamax once weekly, Actonel once weekly, and Boniva once monthly among post-menopausal women in the USA. J Bone Min Res 2006;21:S183
   Google Scholar
• Gold D, Safi W, Trihn H. Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate. Curr Med Res Opin 2006;22:2383–91
   Google Scholar
• Weiss TW, Henderson SC, McHorney CA, Cramer JA. Persistency rates across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills. Curr Med Res Opin 2007;23:2193–202
   PubMed Web of Science ®Google Scholar
• Duarte JW, Bolge SC, Sen SS. An evaluation of patients’ preferences for osteoporosis medications and their attributes: the PREFER-International Study. Clin Ther 2007;29: 488–502
   Google Scholar
• Weiss T, McHorney C. Osteoporosis medication profile prefer ence: results from the PREFER-US Study. Health Expect 2007;10:211–23
   PubMed Web of Science ®Google Scholar
• Likert R. A technique for the measurement of attitudes. Arch Psychol 1932;140:5–55
   Google Scholar
• The American Association for Public Opinion Research. Standard definitions: final dispositions of case codes and outcomes rates for surveys. Available at:http://www.aapor. org/standards.asp [Last accessed 5 May 2007]
   Google Scholar
• Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334
   Web of Science ®Google Scholar
• Hattie J. Methodology review: assessing the unidimensionality of tests and items. Appl Psychol Meas 1985;9:139–164
   Web of Science ®Google Scholar
• Reise S, Henson J. Computerization and adaptive administration of the NEO PI-R. Assessment 2000;7:347–67
   PubMed Web of Science ®Google Scholar
• Teresi J, Kleinman M, Ocepek K. Modern psychometric methods for detection of differential item functioning: application to cognitive assessment measures. Stat Med 2000;19:1651–83
   Google Scholar
• Caro G, Caro J, O’Brien J, et al. Migraine therapy: development and testing of a patient preference questionnaire. Headache 1998;38:602–7
   Google Scholar
• Dahlof C. How to assess patient preference of migraine treatments. Cephalalgia 1999;19:2–6
   PubMed Web of Science ®Google Scholar
• Johnson M, Guilford S, Libretto S. Patients have treatment prefer ences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole. Curr Med Res Opin 2002;18:303–10
   Google Scholar
• Kaliner M. Patient preferences and satisfaction with prescribed nasal steroids for allergic rhinitis. Allergy Asthma Proc 2001;22:S11–15
   PubMed Web of Science ®Google Scholar
• Lipton R, Stewart W. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999;39:S20–6
   Google Scholar
• Loder E, Brandes JL, Silberstein S, et al. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Headache 2001;41:745–53
   PubMed Web of Science ®Google Scholar
• Luciani R, Osterhaus J, Gutterman D. Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications. J Fam Pract 1995;41:147–52
   Google Scholar
• Salonen R, Ashford E, Gibbs M, et al. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Int J Clin Pract Suppl. 1999;105:16–24
   PubMedGoogle Scholar
• Hansen HV, Kessing LV. Adherence to antidepressant treatment. Expert Rev Neurother 2007;7:57–62
   PubMedGoogle Scholar
• Smith MY, Rapkin BD, Morrison A, Kammerman S. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy. J Gen Intern Med 1997;12:216–23
   Google Scholar
• Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immuno-deficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med 1992;92:495–502
   PubMed Web of Science ®Google Scholar
• Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004;42:626–34
   PubMed Web of Science ®Google Scholar
• Piette JD, Heisler M, Wagner TH. Cost-related medication under use among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004;94:1782–7
   Google Scholar
• Wilson IB, Schoen C, Neuman P, et al. Physician-patient com munication about prescription medication nonadherence: a 50-state study of America’s seniors. J Gen Intern Med 2007;22:6–12
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2007, Published article online: 25 Jun 2007 doi:1111/j.1524–4733.2007.00213.x
   Google Scholar
• Herzog AR, Rodgers WL. Age and response rates to interview sample surveys. J Gerontol 1988;43:S200–5
   PubMedGoogle Scholar
• Herzog AR, Kulka RA. Telephone and mail surveys with older populations: a methodological overview. In: Lawton MP, Herzog AR, eds. Special Research Methodology for Gerontology. Amityville, NY: Baywood Publishing Company, 1989:63–89
   Google Scholar
• Martin C. The impact of topic interest on mail survey response behavior. J Market Res Soc 1994;36:327–38
   Web of Science ®Google Scholar
• Lundberg O, Thorslund M. Fieldwork and measurement consider ations in surveys of the oldest old. Social Indicators Res 1996;37:165–87
   Web of Science ®Google Scholar
• Groves R, Presser S, Dipko S. The role of topic interest in survey participation decisions. Public Opin Q 2004;68: 2–31
   Google Scholar
• Lambert N, Rowe G, Bowling A, et al. Reasons underpinning patients’ preferences for various angina treatments. Health Expect 2004;7:246–56
   PubMed Web of Science ®Google Scholar